Skip to main content

Year: 2022

ING Group 2022 SREP process completed

ING Group 2022 SREP process completed ING Group has been notified of the European Central Bank (ECB) decision on the 2022 Supervisory Review and Evaluation Process (SREP), based on which it has taken a decision on ING’s prudential requirements, including capital requirements for 2023. ING Group’s fully loaded CET1 requirement is 10.96%, reflecting a countercyclical capital buffer of 47bps (fully loaded per Q3 2023). The current countercyclical capital buffer for ING Group is 4bps. In terms of Pillar 2 additional own funds requirement for ING Group, the outcome remained unchanged at 175bps, applicable per 1 January 2023. As of 30 September 2022, ING’s fully-loaded CET1 ratio was 14.7%, well in excess of the regulatory requirements. Further information on ING’s capital requirements can be found in the ING Group Credit Update presentation...

Continue reading

Ignitis Group wind farm secured incentive tariff in Poland

Silesia 2 wind farm, owned by Ignitis renewables, a subsidiary of Ignitis Group, has secured a Contract for Difference incentive tariff for a portion of the wind farm’s annual electricity output in the Polish auction system for renewables. Indexed yearly for an inflation, 274.99 PLN/MWh (59 EUR/MWh) tariff has been secured for 35% of the total planned electricity production during a 15-year tariff period and will significantly reduce electricity price volatility risk. The remaning electricity volume of the wind farm will be either realized on the market or contracted via long term energy sale agreements. A 137 MW installed capacity Silesia 2 wind farm is currently under construction with an estimated COD in 2024. The closing of Silesia 2 acquisition transaction took place in November 2022 – as previously announced (link) – and is a significant...

Continue reading

Ignitis Group wind farm secured incentive tariff in Poland

Silesia 2 wind farm, owned by Ignitis renewables, a subsidiary of Ignitis Group, has secured a Contract for Difference incentive tariff for a portion of the wind farm’s annual electricity output in the Polish auction system for renewables. Indexed yearly for an inflation, 274.99 PLN/MWh (59 EUR/MWh) tariff has been secured for 35% of the total planned electricity production during a 15-year tariff period and will significantly reduce electricity price volatility risk. The remaning electricity volume of the wind farm will be either realized on the market or contracted via long term energy sale agreements. A 137 MW installed capacity Silesia 2 wind farm is currently under construction with an estimated COD in 2024. The closing of Silesia 2 acquisition transaction took place in November 2022 – as previously announced (link) – and is a significant...

Continue reading

AB Science announces the drawdown of the first tranche of 6 million euros under its financing agreement with the European Investment Bank

PRESS RELEASE AB SCIENCE ANNOUNCES THE DRAWDOWN OF THE FIRST TRANCHE OF 6 MILLION EUROS UNDER ITS FINANCING AGREEMENT WITH THE EUROPEAN INVESTMENT BANK Paris, December 22, 2022, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) announced today that it has received payment of €6.0 million as the first tranche of a €15 million loan from the European Investment Bank (EIB). As previously announced [1], the agreement signed with the EIB provides a financing in two tranches of EUR 6.0 million and a third tranche of EUR 3.0 million, each subject to the fulfillment of certain conditions precedent, which have been satisfied for the first two tranches. Each tranche is accompanied by the issue of warrants, the number of which is calculated in relation to a reference price of 14 euros according to the following formula : Number of warrants...

Continue reading

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2022

Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2022 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (December 22, 2022 – 6:00 pm) – As of November 30, 2022, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.  November 30, 2022Shares outstanding           447,452,7641Number of real voting rights (excluding treasury shares) 444,659,008Theoretical number of voting rights (including treasury shares) 447,452,764It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with...

Continue reading

Sjóvá – Fjárhagsdagatal ársins 2023

Sjóvá-Almennar tryggingar hf. stefnir að birtingu árshluta- og ársuppgjöra á neðangreindum dagsetningum:Ársuppgjör 2022                            9. febrúar 2023 1. ársfjórðungur 2023                  1. júní 2023 2. ársfjórðungur 2023                  31. ágúst 2023 3. ársfjórðungur 2023                  26. október 2023 Ársuppgjör 2023                            8. febrúar 2024Aðalfundir verða haldnir á neðangreindum dagsetningum:Aðalfundur 2023                       10. mars 2023 Aðalfundur 2024                       7. mars 2024Dagsetningarnar eru birtar með fyrirvara um breytingar.

Continue reading

Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor

Broomfield, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that Dr. Christopher Ames, Director of Spinal Deformity and Spine Tumor Surgery and Co-Director of the Combined High Risk Spine Service, the Neurospinal Disorders Program, and the UCSF Spine Center at the University of California at San Francisco will advise the company as a Key Opinion Leader (KOL) nationally.  Chronic low back pain (cLBP) is a leading cause of opioid addiction in the U.S. and the single most expensive diagnosis in the United States.  Aclarion’s Nociscan solution is the first evidence-supported...

Continue reading

Brunswick Exploration Closes Financings for Gross Proceeds of C$5.5 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Dec. 22, 2022 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (“BRW” or the “Company“) is pleased to announce the closing of its previously announced private placements for aggregate gross proceeds of C$5,500,240. Mr. Killian Charles, President of BRW, commented: “With the closing of this financing, we are now fully financed to launch one of the largest grassroot lithium exploration programs globally. We believe 2023 will be an exciting year for the Company as we look to begin filtering the hundreds of untested pegmatites in our portfolio.” The Company has completed its “best-efforts” private placement (the “Brokered Offering”) led by Red Cloud Securities Inc. on behalf of a syndicate of agents that includes Canaccord...

Continue reading

Independent Bank Corporation Announces Date for Its Fourth Quarter 2022 Earnings Release

GRAND RAPIDS, Mich., Dec. 22, 2022 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2022 fourth quarter results on Thursday, January 26, 2023, at approximately 8:00 am ET. The release will be available on the Internet at IndependentBank.com within the “News” section of the “Investor Relations” area of the Company’s website. Brad Kessel, President and CEO, Gavin Mohr, CFO and Joel Rahn, EVP Commercial Banking will review the quarterly results in a conference call for investors and analysts beginning at 11:00 am ET on Thursday, January 26, 2023. To participate in the live conference call, please dial 1-844-200-6205 (Access Code # 132616). Also the conference call will be accessible through an audio webcast...

Continue reading

2022 no. 18 – Publication of major shareholder announcements

Aalborg, 22 December 2022Sanistål A/S (“Sanistål”) has received major shareholder notifications submitted pursuant to chapter 7 of Consolidated Act no. 2014 of 1 November 2021 on capital markets (the “Capital Markets Act”), as amended. As announced in company announcement no. 8 / 2022, Ahlsell Danmark ApS (“Ahlsell”) announced on 24 May 2022 that Ahlsell had entered into conditional share purchase agreements with Danske Bank A/S, Nordea Bank Abp, Jyske Bank A/S and Nykredit Bank A/S to acquire approximately 75.49% of the shares in Sanistål at a price of DKK 58 per share. As the necessary regulatory approvals have been obtained (please refer to company announcement no. 16 / 2022), these agreements have now been completed. Accordingly, each of the banks hold less than 5% of the total share capital and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.